200 is a clinical research site located in Baltimore, Maryland, United States 21218.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
200 has participated in 1 clinical trials.
Therapeutic areas: Hypertension, Diabetes Mellitus, Type 2.
Sponsors: Boehringer Ingelheim.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
200 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
200 has 1 clinical trials on record. Their work covers Hypertension, Diabetes Mellitus, Type 2.
200 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.